Published in Neurosurgery on December 01, 1988
Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A (1994) 6.61
Immunotherapy of malignant brain tumors. Immunol Rev (2008) 1.20
Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas. Am J Pathol (1996) 0.96
A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy. J Immunol Res (2014) 0.85
Glioma stem cells and immunotherapy for the treatment of malignant gliomas. ISRN Oncol (2013) 0.84
Metastatic renal cell cancer--is the outlook really improving? Postgrad Med J (1990) 0.75
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94
Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science (1994) 3.46
Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature (1994) 3.31
A fluid percussion model of experimental brain injury in the rat. J Neurosurg (1987) 3.13
The outcome from severe head injury with early diagnosis and intensive management. J Neurosurg (1977) 3.09
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. J Neurosurg (1993) 2.37
Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg (1991) 2.09
Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg (1996) 2.07
Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer (1981) 2.05
Prediction tree for severely head-injured patients. J Neurosurg (1991) 1.97
Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J Neurosurg (1990) 1.91
Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography. J Neurosurg (1992) 1.88
Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci U S A (1994) 1.84
Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med (1995) 1.78
Further experience in the management of severe head injury. J Neurosurg (1981) 1.66
Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg (1998) 1.63
Mutation of Tec family kinases alters T helper cell differentiation. Nat Immunol (2001) 1.63
Prolonged memory impairment in the absence of hippocampal cell death following traumatic brain injury in the rat. Brain Res (1990) 1.55
Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc Natl Acad Sci U S A (1992) 1.55
Cerebral circulation and metabolism after severe traumatic brain injury: the elusive role of ischemia. J Neurosurg (1991) 1.54
Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic cytokines. J Exp Med (1993) 1.53
Intracranial pressure: to monitor or not to monitor? A review of our experience with severe head injury. J Neurosurg (1982) 1.49
Beta-endorphin in cerebrospinal fluid and serum after severe head injury. Neurosurgery (1990) 1.42
Tec family kinases modulate thresholds for thymocyte development and selection. J Exp Med (2000) 1.41
Outcome after severe head injury. Relationship to mass lesions, diffuse injury, and ICP course in pediatric and adult patients. J Neurosurg (1987) 1.33
Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood (2000) 1.31
The ever-expanding Ly49 gene family: repertoire and signaling. Immunol Rev (2001) 1.26
Diffuse brain swelling in severely head-injured children. A report from the NIH Traumatic Coma Data Bank. J Neurosurg (1992) 1.19
Real time data acquisition: recommendations for the Medical Information Bus (MIB). Int J Clin Monit Comput (1992) 1.18
A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. Effects of herbimycin A. J Immunol (1992) 1.17
Evidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical events. Ann N Y Acad Sci (1995) 1.16
Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med (1995) 1.14
Combined craniofacial resection for locally advanced carcinoma of the head and neck II. Carcinoma of the paranasal sinuses. Am J Surg (1980) 1.12
Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur J Immunol (1995) 1.12
Contribution of edema and cerebral blood volume to traumatic brain swelling in head-injured patients. J Neurosurg (2000) 1.11
Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J Leukoc Biol (1999) 1.08
Cerebral blood flow and metabolism in severely head-injured children. Part 1: Relationship with GCS score, outcome, ICP, and PVI. J Neurosurg (1989) 1.07
Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J Immunol (1998) 1.06
The relationship of intelligence and cerebral mantle in treated infantile hydrocephalus. (IQ potential in hydrocephalic children). Pediatrics (1973) 1.03
Intracranial extension of an eccrine porocarcinoma. Case report and review of the literature. J Neurosurg (1999) 1.01
Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2. Blood (1995) 1.01
Real time data acquisition: experience with the Medical Information Bus (MIB). Proc Annu Symp Comput Appl Med Care (1991) 1.00
Hyperglycemia, cerebrospinal fluid lactic acidosis, and cerebral blood flow in severely head-injured patients. Neurosurgery (1987) 1.00
Continuous monitoring of cerebral substrate delivery and clearance: initial experience in 24 patients with severe acute brain injuries. Neurosurgery (1997) 0.99
Functional association of FcepsilonRIgamma with arginine(632) of paired immunoglobulin-like receptor (PIR)-A3 in murine macrophages. Blood (1999) 0.97
Effects of prolonged cerebrospinal fluid shunting on the skull and brain. J Neurosurg (1973) 0.95
Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke (1995) 0.95
Correlations between brain tissue oxygen tension, carbon dioxide tension, pH, and cerebral blood flow--a better way of monitoring the severely injured brain? Surg Neurol (1998) 0.95
Closure of craniofacial defects after cancer resection. Am J Surg (1991) 0.95
Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID). J Immunol (1994) 0.94
Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J Immunol (1995) 0.93
Unusual, rod-shaped cytoplasmic inclusions (Hirano bodies) in a cerebellar hemangioblastoma. Acta Neuropathol (1975) 0.92
Substance abuse and crime patterns among persons with traumatic brain injury referred for supported employment. Brain Inj (1991) 0.92
Toxoplasma gondii: molecular cloning and characterization of a novel 18-kDa secretory antigen, TgMIC10. Exp Parasitol (2001) 0.92
Contribution of CSF and vascular factors to elevation of ICP in severely head-injured patients. J Neurosurg (1987) 0.91
Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2. Cancer (1988) 0.90
Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl (1998) 0.90
Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J Immunol (1997) 0.89
High thoracic disc herniation. Neurosurgery (1986) 0.89
Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol (1976) 0.89
Brain oxygen, CO2, pH, and temperature monitoring: evaluation in the feline brain. Neurosurgery (1995) 0.88
Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion. J Neurosurg (1998) 0.88
Paired inhibitory and activating receptor signals. Rev Immunogenet (2000) 0.88
Glutamate release and cerebral blood flow after severe human head injury. Acta Neurochir Suppl (1996) 0.88
Posttraumatic ventriculomegaly: hydrocephalus or atrophy? A new approach for diagnosis using CSF dynamics. J Neurosurg (1996) 0.88
Ventriculostomy for hydrocephalus in cerebellar hemorrhage. Neurology (1981) 0.87
Bilateral acute subdural hematomas undiagnosed by computerized tomography: case report. Neurosurgery (1979) 0.87
Three-year outcome of shunted idiopathic NPH patients. Acta Neurochir Suppl (2005) 0.87
Pretreatment with phencyclidine, an N-methyl-D-aspartate antagonist, attenuates long-term behavioral deficits in the rat produced by traumatic brain injury. J Neurotrauma (1988) 0.87
Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations. J Neurooncol (1990) 0.86
Cloning and characterization of a novel activating Ly49 closely related to Ly49A. J Immunol (1999) 0.86
Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors. J Immunol (1999) 0.86
Blue-domed cyst with optic nerve compression. J Neurol Neurosurg Psychiatry (1978) 0.86
Multiparametric continuous monitoring of brain metabolism and substrate delivery in neurosurgical patients. Neurol Res (1997) 0.85
Giant intrasacral schwannoma: an unusual cause of lumbrosacral radiculopathy. Surg Neurol (1994) 0.85
IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes. J Exp Med (1994) 0.85
Production and clearance of lactate from brain tissue, cerebrospinal fluid, and serum following experimental brain injury. J Neurosurg (1988) 0.85
Effects of anticholinergic treatment on transient behavioral suppression and physiological responses following concussive brain injury to the rat. Brain Res (1988) 0.85
Temporal profile of outcomes in severe head injury. J Neurosurg (1994) 0.85
The use of the laser in neurological surgery. Surg Neurol (1980) 0.85
Combined pretrauma scopolamine and phencyclidine attenuate posttraumatic increased sensitivity to delayed secondary ischemia. J Neurotrauma (1988) 0.84
Regional rates of glucose utilization in the cat following concussive head injury. J Neurotrauma (1988) 0.84
Comparison of nurse and computer recording of ICP in head injured patients. J Neurosci Nurs (1988) 0.84
Monitoring in patients with brain tumors. Clin Neurosurg (1975) 0.83
Effects of scopolamine treatment on long-term behavioral deficits following concussive brain injury to the rat. Brain Res (1988) 0.83
Corticosteroids inhibit the generation of lymphokine-activated killer activity in vitro. Cancer Immunol Immunother (1989) 0.83
Regulation of NK cells through the 80-kDa TNFR (CD120b). J Leukoc Biol (1995) 0.82
Herpesvirus type 1 serum antibodies and brain tumors in humans. Clin Neuropathol (1984) 0.82
Increased proliferation, cytotoxicity, and gene expression after stimulation of human peripheral blood T lymphocytes through a surface ganglioside (GD3) J Immunol (1994) 0.82
Granulomatous angiitis with preceding varicella zoster. Ann Neurol (1978) 0.81
Nutrition and the neurosurgical patient. J Neurosurg (1984) 0.81
Physiological effects of dimethyl sulfoxide on peripheral nerves: possible role in pain relief. Exp Neurol (1969) 0.80
Low extracellular (ECF) glucose affects the neurochemical profile in severe head-injured patients. Acta Neurochir Suppl (2000) 0.80
Effects of the allosteric modification of hemoglobin on brain oxygen and infarct size in a feline model of stroke. Stroke (1997) 0.80
Microsurgical cerebral revascularization for the treatment of stroke. Va Med (1978) 0.80
Follow-up study of 103 American soldiers who sustained a brain wound in Vietnam. J Neurosurg (1974) 0.80